This panel brings together leading researchers to explore how health economics can inform policy design in the context of the climate crisis. Rather than proposing ...

What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

In our latest insight, we reflect on what we’re seeing in the region, from Saudi Arabia’s Vision 2030 to the UAE’s push for innovation and value in healthcare.

Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

OECD countries formally use QALYs in pricing and reimbursement decisions. See how HTA practices differ and where policies ...

Spending Review: £29bn for NHS. OHE’s Graham Cookson calls for clarity on productivity and investment in prevention for long-term sustainability.

A new interactive Respiratory Cost Calculator, developed by OHE, commissioned and owned by Pfizer, enables employers to estimate the financial impact of absenteeism and presenteeism due to short-term ...

The Office of Health Economics launched the OHE Innovation Policy Prize in 2022; a biennial prize fund to promote thought leadership and solution-based theories around ...

In this Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. The authors express ...